Mechanistic Studies of the Multiple Myeloma and Melanoma Cell-Selective Toxicity of the Rpn13-Binding Peptoid KDT-11-Reference-Cited by-同舟云学术

Mechanistic Studies of the Multiple Myeloma and Melanoma Cell-Selective Toxicity of the Rpn13-Binding Peptoid KDT-11

Published:2020-11 Issue:11 Volume:27 Page:1383-1395.e5
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Dickson Paige,Simanski Scott^ORCID,Ngundu John Maina,Kodadek Thomas

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference35 articles.

1. Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development;Al-Shami;PLoS One,2010

2. A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer;Anchoori;Cancer Cell,2013

3. Knockdown of the novel proteasome subunit Adrm1 located on the 20q13 amplicon inhibits colorectal cancer migration, survivability and tumorigenicity;Chen;Oncol. Rep.,2009

4. Inhibition of proteasome deubiquitinating activity as a new cancer therapy;D'Arcy;Nat. Med.,2011

5. Deubiquitinase inhibition as a cancer therapeutic strategy;D'Arcy;Pharmacol. Ther.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Linker optimization and activity validation of a cell surface vimentin targeted homo-dimeric peptoid antagonist for lung cancer stem cells;Bioorganic & Medicinal Chemistry;2024-01

2. Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling;Experimental Hematology & Oncology;2023-11-09

3. Quantitative and Nondestructive Colorimetric Amine Detection Method for the Solid-Phase Peptide Synthesis as an Alternative to the Kaiser Test;Analytical Chemistry;2023-10-13

4. Recent advances in anticancer peptoids;Bioorganic Chemistry;2023-10

5. Exploiting the Proteasome for Disease Treatment;Protein Homeostasis in Drug Discovery;2022-11-14